Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on the U.S. - Session 7

Webinar No.7: DEI under the new administration: What you need to know

We are delighted to invite you to the seventh session of our “Spotlight on the U.S.” sessions within our APAC life sciences and health care webinar series on Thursday, 3 April 2025.

President Trump has made quick work of signing multiple executive orders addressing a broad range of issues since his inauguration in January. And diversity, equity, and inclusion (DEI) policies were among the first to be addressed by this new administration.

These actions will have a significant impact on healthcare and life sciences companies because the U.S. government is the biggest purchaser of healthcare products and services in the United States. The changes present potential increased risk of litigation and government investigations for U.S. and multinational healthcare and life sciences businesses. Furthermore, companies will be navigating these challenges with cross-currents from conflicting laws in other jurisdictions and the demands of employees, investors, and consumers.

To help you better understand this rapidly changing DEI landscape, we are hosting a webinar covering the following topics:

  • Overview of executive orders and agency guidance to date – What is “Illegal DEI”?
  • Considerations for government contractors – How the executive orders are affecting your obligations.
  • Public company considerations – Understanding the rapid shift in disclosure and governance environment.
  • Civil litigation risk – Emerging trends in litigation.
  • Government investigations risk – Understanding the threat of criminal cases and civil investigations, including under the False Claims Act.

If you have any questions, please submit them in advance and our speakers will seek to address them during the webinar.

We hope you can join us.

 

Register here


Back To Listing